ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 83 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $665,000 | -32.3% | 86,206 | +0.3% | 0.00% | 0.0% |
| Q3 2016 | $982,000 | +26.7% | 85,924 | +36.5% | 0.00% | 0.0% |
| Q2 2016 | $775,000 | +29.6% | 62,957 | +6.4% | 0.00% | 0.0% |
| Q1 2016 | $598,000 | -55.1% | 59,165 | +0.0% | 0.00% | -50.0% |
| Q4 2015 | $1,333,000 | +36.9% | 59,155 | +0.8% | 0.00% | +100.0% |
| Q3 2015 | $974,000 | -27.9% | 58,689 | -2.2% | 0.00% | -50.0% |
| Q2 2015 | $1,351,000 | +41.9% | 60,023 | +62.5% | 0.00% | +100.0% |
| Q1 2015 | $952,000 | +19.7% | 36,936 | +1.1% | 0.00% | 0.0% |
| Q4 2014 | $795,000 | +13.6% | 36,544 | -1.1% | 0.00% | 0.0% |
| Q3 2014 | $700,000 | -16.8% | 36,960 | +2.4% | 0.00% | 0.0% |
| Q2 2014 | $841,000 | +84.8% | 36,105 | +167.3% | 0.00% | 0.0% |
| Q1 2014 | $455,000 | +20.4% | 13,507 | +5.4% | 0.00% | 0.0% |
| Q4 2013 | $378,000 | +104.3% | 12,811 | +6.0% | 0.00% | – |
| Q3 2013 | $185,000 | – | 12,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 1,839,730 | $16,944,000 | 4.17% |
| BVF INC/IL | 1,760,489 | $16,214,000 | 2.76% |
| Iguana Healthcare Management, LLC | 490,000 | $4,513,000 | 2.23% |
| Broadfin Capital, LLC | 300,000 | $2,763,000 | 0.34% |
| TURNER INVESTMENTS LLC | 38,083 | $351,000 | 0.23% |
| Birchview Capital, LP | 34,689 | $319,000 | 0.18% |
| Piermont Capital Management Inc. | 52,195 | $481,000 | 0.12% |
| Cannell & Co. | 331,296 | $3,051,000 | 0.11% |
| NJ State Employees Deferred Compensation Plan | 48,000 | $442,000 | 0.08% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 324,350 | $2,987,000 | 0.07% |